Literature DB >> 19412381

Antimicrobial stewardship in acute care centres: A survey of 68 hospitals in Quebec.

Vincent Nault1, Mathieu Beaudoin, Daniel Jg Thirion, Michel Gosselin, Benoit Cossette, Louis Valiquette.   

Abstract

BACKGROUND: Antimicrobial stewardship programs (ASPs) and quantitative monitoring of antimicrobial use are required to ensure that antimicrobials are used appropriately in the acute care setting, and have the potential to reduce costs and limit the spread of antimicrobial-resistant organisms and Clostridium difficile. Currently, it is not known what proportion of Quebec hospitals have an ASP and/or monitor antimicrobial use.
OBJECTIVES: To determine what proportion of Quebec hospitals have an ASP, and what is the nature of such a program.
METHODS: A detailed questionnaire was sent to the pharmacy directors of all acute care hospitals in the province of Quebec. Information was collected on antimicrobial surveillance; antimicrobial stewardship and resource allocation to these areas were assessed.
RESULTS: Questionnaires were completed for 68 of 81 (84%) hospitals contacted. ASPs were identified at 50 (74%) hospitals, but only 20 (29%) of hospitals had a quantitative antimicrobial surveillance program (QASP) in 2006. Academic centres (P=0.03) and hospitals with over 200 beds (P=0.02) were more likely to have a QASP. Even among hospitals with an ASP, 18% had less than one full-time pharmacist for a QASP.
CONCLUSIONS: Over one-quarter of Quebec hospitals do not have an ASP, and few hospitals in Quebec are currently evaluating their use of antimicrobials on a quantitative basis. In some cases, the lack of a QASP may be due to the allocation of insufficient pharmaceutical resources to antimicrobial stewardship (ie, less than one full-time pharmacist).

Entities:  

Keywords:  Antimicrobial stewardship; Antimicrobials; Guidelines; Survey

Year:  2008        PMID: 19412381      PMCID: PMC2605871          DOI: 10.1155/2008/845651

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  14 in total

1.  Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America/Infectious Diseases Society of America.

Authors:  R M Lawton; S K Fridkin; R P Gaynes; J E McGowan
Journal:  Infect Control Hosp Epidemiol       Date:  2000-04       Impact factor: 3.254

2.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

3.  Appropriateness of antimicrobial therapy measured by repeated prevalence surveys.

Authors:  Ina Willemsen; Anneke Groenhuijzen; Diana Bogaers; Arie Stuurman; Peter van Keulen; Jan Kluytmans
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

4.  Projecting future drug expenditures--2007.

Authors:  James M Hoffman; Nilay D Shah; Lee C Vermeulen; Glen T Schumock; Penny Grim; Robert J Hunkler; Karrie M Hontz
Journal:  Am J Health Syst Pharm       Date:  2007-02-01       Impact factor: 2.637

Review 5.  Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital.

Authors:  J F John; N O Fishman
Journal:  Clin Infect Dis       Date:  1997-03       Impact factor: 9.079

6.  Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America.

Authors:  J J Marr; H L Moffet; C M Kunin
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

7.  Survey of antibiotic control policies in university-affiliated teaching institutions.

Authors:  T S Lesar; L L Briceland
Journal:  Ann Pharmacother       Date:  1996-01       Impact factor: 3.154

Review 8.  Clostridium difficile-associated diarrhea and colitis.

Authors:  D N Gerding; S Johnson; L R Peterson; M E Mulligan; J Silva
Journal:  Infect Control Hosp Epidemiol       Date:  1995-08       Impact factor: 3.254

9.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors:  Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

Review 10.  Clostridium difficile-associated diarrhea in adults.

Authors:  Susan M Poutanen; Andrew E Simor
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

View more
  2 in total

1.  Selection of hospital antimicrobial prescribing quality indicators: a consensus among German antibiotic stewardship (ABS) networkers.

Authors:  J Thern; K de With; R Strauss; M Steib-Bauert; N Weber; W V Kern
Journal:  Infection       Date:  2013-12-11       Impact factor: 3.553

Review 2.  Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship.

Authors:  Philippe Morency-Potvin; David N Schwartz; Robert A Weinstein
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.